Publication | Open Access

Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes

Metabolic SyndromeHypertensionDiabetes ManagementCardiovascular DiseaseMedicineDiabetesPharmacologyPhysiologyVascular BiologyExperimental DiabetesDiabetes MellitusChronic Kidney DiseaseAngiotensin Ii AntagonistHmg-coa Reductase InhibitorHealth Sciences